{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,8]],"date-time":"2026-07-08T05:02:32Z","timestamp":1783486952230,"version":"3.55.0"},"reference-count":28,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2006,12,1]],"date-time":"2006-12-01T00:00:00Z","timestamp":1164931200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["European Journal of Internal Medicine"],"published-print":{"date-parts":[[2006,12]]},"DOI":"10.1016\/j.ejim.2006.04.013","type":"journal-article","created":{"date-parts":[[2006,12,2]],"date-time":"2006-12-02T09:24:32Z","timestamp":1165051472000},"page":"545-550","source":"Crossref","is-referenced-by-count":48,"title":["Determination of oxidative stress in thyroid tissue and plasma of patients with Graves' disease"],"prefix":"10.1016","volume":"17","author":[{"given":"Evin","family":"Ademo\u011flu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ne\u015fe","family":"\u00d6zbey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ye\u015fim","family":"Erbil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sevda","family":"Tanrikulu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Umut","family":"Barbaros","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Burcu Tulumo\u011flu","family":"Yanik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alp","family":"Bozbora","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sel\u00e7uk","family":"\u00d6zarma\u011fan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejim.2006.04.013_bib1","first-page":"15","article-title":"Determination of carbonyl groups in oxidized proteins","volume":"99","author":"Levine","year":"2000","journal-title":"Methods Mol Biol"},{"key":"10.1016\/j.ejim.2006.04.013_bib2","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1111\/j.1749-6632.2000.tb06187.x","article-title":"Protein oxidation","volume":"899","author":"Stadtman","year":"2000","journal-title":"Ann NY Acad Sci"},{"key":"10.1016\/j.ejim.2006.04.013_bib3","first-page":"99","article-title":"Human studies related to protein oxidation: protein carbonyl content as a marker of damage","volume":"33","author":"Chevion","year":"2000","journal-title":"Free Radic Res"},{"issue":"11","key":"10.1016\/j.ejim.2006.04.013_bib4","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.1515\/cclm.2002.198","article-title":"Antioxidant status in thyroid dysfunction","volume":"40","author":"Resch","year":"2002","journal-title":"Clin Chem Lab Med"},{"issue":"10","key":"10.1016\/j.ejim.2006.04.013_bib5","doi-asserted-by":"crossref","first-page":"3421","DOI":"10.1210\/jc.82.10.3421","article-title":"Both hypothyroidism and hyperthyroidism enhance low density lipoprotein oxidation","volume":"82","author":"Sundaram","year":"1997","journal-title":"J Clin Endocrinol Metab"},{"issue":"3","key":"10.1016\/j.ejim.2006.04.013_bib6","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1046\/j.1365-2265.2003.01850.x","article-title":"Peripheral parameters of oxidative stress in Graves' disease: the effects of methimazole and 131 iodine treatments","volume":"59","author":"Abalovich","year":"2003","journal-title":"Clin Endocrinol"},{"issue":"6","key":"10.1016\/j.ejim.2006.04.013_bib7","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1080\/10715760410001701621","article-title":"Oxidation products and antioxidant markers in plasma of patients with Graves' disease and toxic multinodular goiter: effect of methimazole treatment","volume":"38","author":"Bednarek","year":"2004","journal-title":"Free Radic Res"},{"key":"10.1016\/j.ejim.2006.04.013_bib8","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/j.imlet.2004.03.020","article-title":"Peripheral parameters of oxidative stress in patients with infiltrative Graves' ophthalmopathy treated with corticosteroids","volume":"15","author":"Bednarek","year":"2004","journal-title":"Immunol Lett"},{"key":"10.1016\/j.ejim.2006.04.013_bib9","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1210\/er.21.2.168","article-title":"Management of Graves ophthalmopathy : reality and perspectives","volume":"21","author":"Bartalena","year":"2000","journal-title":"Endocr Rev"},{"key":"10.1016\/j.ejim.2006.04.013_bib10","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1016\/S0076-6879(78)52032-6","article-title":"Microsomal lipid peroxidation","volume":"52","author":"Buege","year":"1978","journal-title":"Methods Enzymol"},{"key":"10.1016\/j.ejim.2006.04.013_bib11","first-page":"157","article-title":"Studies on the quantitative and qualitative characterisation of erythrocyte glutathione peroxidase","volume":"70","author":"Paglia","year":"1967","journal-title":"J Lab Clin Med"},{"key":"10.1016\/j.ejim.2006.04.013_bib12","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/0009-8981(94)90108-2","article-title":"Suitability of cooper chloride as a reaction terminator for superoxide dismutase activity assay","volume":"226","author":"Sun","year":"1994","journal-title":"Clin Chim Acta"},{"key":"10.1016\/j.ejim.2006.04.013_bib13","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1016\/S0076-6879(94)33044-1","article-title":"Measurement of protein thiol groups and glutathione in plasma","volume":"233","author":"Hu","year":"1994","journal-title":"Methods Enzymol"},{"key":"10.1016\/j.ejim.2006.04.013_bib14","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/S0009-8981(00)00306-5","article-title":"Free radical activity and antioxidant defense mechanisms in patients with hyperthyroidism due to Graves' disease during therapy","volume":"300","author":"Komosinska-Vassev","year":"2000","journal-title":"Clin Chim Acta"},{"issue":"11","key":"10.1016\/j.ejim.2006.04.013_bib15","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1055\/s-2007-978808","article-title":"Oxidative stress and anti-oxidant metabolites in patients with hyperthyroidism: effect of treatment","volume":"31","author":"Bianchi","year":"1999","journal-title":"Horm Metab Res"},{"issue":"1","key":"10.1016\/j.ejim.2006.04.013_bib16","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1677\/joe.1.05968","article-title":"Nongenomic effect of thyroid hormone on free-radical production in human polymorphonuclear leukocytes","volume":"185","author":"Mezosi","year":"2000","journal-title":"J Endocrinol"},{"key":"10.1016\/j.ejim.2006.04.013_bib17","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1016\/S0009-9120(99)00024-7","article-title":"Effects of propylthiouracil, propranolol, and vitamin E on lipid peroxidation and antioxidant status in hyperthyr\u00fdoid patients","volume":"32","author":"Adal\u00fd","year":"1999","journal-title":"Clin Biochem"},{"key":"10.1016\/j.ejim.2006.04.013_bib18","first-page":"669","article-title":"Thiourea and dimethylthiourea inhibit peroxynitrite-dependent damage: non specificity as hydroxyradical scavengers","volume":"14","author":"Whiteman","year":"1993","journal-title":"Free Radic Biol Med"},{"issue":"4","key":"10.1016\/j.ejim.2006.04.013_bib19","first-page":"623","article-title":"Hyperthyroidism: diagnosis and treatment","volume":"72","author":"Reid","year":"2005","journal-title":"Am Fam Phys"},{"key":"10.1016\/j.ejim.2006.04.013_bib20","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1089\/thy.1998.8.571","article-title":"Thyroid nodules in Graves' disease: classification, characterization, and response to treatment","volume":"8","author":"Carnell","year":"1988","journal-title":"Thyroid"},{"key":"10.1016\/j.ejim.2006.04.013_bib21","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.clinbiochem.2004.09.015","article-title":"Oxidative stress peripheral parameters in Graves disease: the effect of methimazole treatment in patients with and without infiltrative ophthalmopathy","volume":"38","author":"Bednarek","year":"2005","journal-title":"Clin Biochem"},{"issue":"suppl2","key":"10.1016\/j.ejim.2006.04.013_bib22","doi-asserted-by":"crossref","first-page":"S58","DOI":"10.1038\/sj.ejcn.1602300","article-title":"Age-related oxidative stress and antioxidant parameters in middle-aged and older European subjects: the ZENITH study","volume":"59","author":"Andriollo-Sanchez","year":"2005","journal-title":"Eur J Clin Nutr"},{"issue":"4","key":"10.1016\/j.ejim.2006.04.013_bib23","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1515\/CCLM.2005.069","article-title":"The effect of antioxidant supplementation on superoxide dismutase activity, Cu and Zn levels, and total antioxidant status in erythrocytes of patients with Graves' disease","volume":"43","author":"Bacic-Vrca","year":"2005","journal-title":"Clin Chem Lab Med"},{"issue":"1\u20132","key":"10.1016\/j.ejim.2006.04.013_bib24","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.cccn.2003.10.028","article-title":"Supplementation with antioxidants in the treatment of Graves' disease; the effect on glutathione peroxidase activity and concentration of selenium","volume":"341","author":"Vrca","year":"2004","journal-title":"Clin Chim Acta"},{"issue":"2","key":"10.1016\/j.ejim.2006.04.013_bib25","first-page":"79","article-title":"Supplementation with antioxidants in the treatment of Graves' disease: the effect on the extracellular antioxidative parameters","volume":"54","author":"Vrca","year":"2004","journal-title":"Acta Pharm"},{"issue":"1\u20132","key":"10.1016\/j.ejim.2006.04.013_bib26","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.cccn.2004.08.020","article-title":"Antioxidants and methimazole in the treatment of Graves' disease: effect on urinary malondialdehyde levels","volume":"352","author":"Guerra","year":"2005","journal-title":"Clin Chim Acta"},{"issue":"3","key":"10.1016\/j.ejim.2006.04.013_bib27","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1089\/thy.1997.7.369","article-title":"Clinical features of patients with Graves' disease undergoing remission after antithyroid drug treatment","volume":"7","author":"Vitti","year":"1997","journal-title":"Thyroid"},{"issue":"9","key":"10.1016\/j.ejim.2006.04.013_bib28","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1056\/NEJMra042972","article-title":"Antithyroid drugs","volume":"352","author":"Cooper","year":"2005","journal-title":"N Engl J Med"}],"container-title":["European Journal of Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0953620506001919?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0953620506001919?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,1,10]],"date-time":"2019-01-10T22:50:58Z","timestamp":1547160658000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0953620506001919"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,12]]},"references-count":28,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2006,12]]}},"alternative-id":["S0953620506001919"],"URL":"https:\/\/doi.org\/10.1016\/j.ejim.2006.04.013","relation":{},"ISSN":["0953-6205"],"issn-type":[{"value":"0953-6205","type":"print"}],"subject":[],"published":{"date-parts":[[2006,12]]}}}